A novel anticancer agent, consisting of a monoclonal antibody linked to a chemotherapy drug, showed substantial anti-tumor activity in ovarian cancer cell lines and in mice, according to a new study.
Full article >>
Saturday, August 8, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment